DafinchiRxSight 2026 Quarterly Forecast for LDD Placements by Region
RxSight's 2026 forecast outlines a cautious, seasonally influenced growth for LDD placements, highlighting quarterly regional dynamics and international expansion beginnings.
Read post
Detailed company information
As a medical technology enterprise, RxSight, Inc. (which operated as Calhoun Vision, Inc. until its rebranding in February 2017) specializes in the innovation, manufacturing, and distribution of light-adjustable intraocular lenses (LALs). These advanced lenses are specifically designed for use in cataract surgery, serving patients in both domestic and international markets. The cornerstone of the company's offerings is the RxSight system, a sophisticated solution that enables ophthalmologists to precisely tailor and enhance a patient's visual acuity following cataract removal. An integral part of this system is the RxSight light delivery device, an in-office instrument. This device emits UV light in a carefully controlled pattern to modify the LAL, thereby ensuring optimal visual correction after the surgical procedure. RxSight's primary clientele consists of eye surgeons specializing in cataract treatments. The company was founded in 1997 and its corporate headquarters are situated in Aliso Viejo, California.
Last Updated: Sep 2026
Earnings Transcript for 2026 - Q2Released: Aug 05, 2026
Earnings Transcript for 2026 - Q1Released: May 09, 2026
Earnings Transcript for 2025 - Q4Released: Feb 25, 2026
Earnings Transcript for 2025 - Q3Released: Nov 05, 2025
Earnings Transcript for 2025 - Q2Released: Aug 08, 2025
Earnings Transcript for 2025 - Q1Released: Apr 03, 2025
Earnings Transcript for 2024 - Q4Released: Feb 25, 2025
Earnings Transcript for 2024 - Q3Released: Nov 09, 2024
Earnings Transcript for 2024 - Q2Released: Aug 05, 2024
Earnings Transcript for 2024 - Q1Released: May 06, 2024
Earnings Transcript for 2023 - Q4Released: Feb 28, 2024
Earnings Transcript for 2023 - Q3Released: Nov 12, 2023
Earnings Transcript for 2023 - Q2Released: Aug 07, 2023
Earnings Transcript for 2023 - Q1Released: May 13, 2023
Earnings Transcript for 2022 - Q4Released: Mar 06, 2023
Earnings Transcript for 2022 - Q3Released: Nov 07, 2022
Earnings Transcript for 2022 - Q2Released: Aug 08, 2022
Earnings Transcript for 2022 - Q1Released: May 09, 2022
Earnings Transcript for 2021 - Q4Released: Mar 08, 2022
Earnings Transcript for 2021 - Q3Released: Nov 10, 2021
LUNG Pulmonx Corporation
SIBN SI-BONE, Inc.
AXGN AxoGen, Inc.
KIDS OrthoPediatrics Corp.
OFIX Orthofix Medical Inc.
VREX Varex Imaging Corporation
TMCI Treace Medical Concepts, Inc.
STAA STAAR Surgical Company
LITE Lumentum Holdings Inc.
OCUL Ocular Therapeutix, Inc.
LNTH Lantheus Holdings, Inc.
ALGN Align Technology, Inc.
RxSight's 2026 forecast outlines a cautious, seasonally influenced growth for LDD placements, highlighting quarterly regional dynamics and international expansion beginnings.
Read post